Results 11 to 20 of about 621,264 (252)

Lactylation and Central Nervous System Diseases [PDF]

Brain Sciences
As the final product of glycolysis, lactate serves as an energy substrate, metabolite, and signaling molecule in various diseases and mediates lactylation, an epigenetic modification that occurs under both physiological and pathological conditions ...
Ye Chen, Dongqiong Xiao, Xihong Li
doaj   +4 more sources

Antibody-mediated central nervous system diseases [PDF]

Brain and Neuroscience Advances, 2018
Antibody-mediated central nervous system diseases are a relatively new area of clinical neuroscience with growing impact. Their recognition has challenged the dogma of the blood–brain barrier preventing antibody access into the central nervous system ...
Maria Pia Giannoccaro, Sarah J. Crisp, Angela Vincent   +2 more
doaj   +4 more sources

A Review on Lactoferrin and Central Nervous System Diseases

Cells, 2021
Central nervous system (CNS) diseases are currently one of the major health issues around the world. Most CNS disorders are characterized by high oxidative stress levels and intense inflammatory responses in affected tissues.
Yu-Qi Li, Chuang Guo
doaj   +3 more sources

Oral microbiota and central nervous system diseases: A review [PDF]

Neuroprotection
Oral microbiota is the second largest microbial colony in the body and forms a complex ecological community that influences oral and brain health. Impaired homeostasis of the oral microbiota can lead to pathological changes, resulting in central nervous ...
Xiaoxuan Zhang, Mengmeng Zhong, Yang Li, Hui Wang, Guangjun Xi, Feng Wang, Chao Cheng, Yachen Shi   +7 more
doaj   +2 more sources

Role of CD36 in central nervous system diseases [PDF]

Neural Regeneration Research
CD36 is a highly glycosylated integral membrane protein that belongs to the scavenger receptor class B family and regulates the pathological progress of metabolic diseases.
Min Feng, Qiang Zhou, Huimin Xie, Chang Liu, Mengru Zheng, Shuyu Zhang, Songlin Zhou, Jian Zhao   +7 more
doaj   +2 more sources

Copper homeostasis and cuproptosis in central nervous system diseases [PDF]

Cell Death and Disease
Copper (Cu), an indispensable micronutrient for the sustenance of living organisms, contributes significantly to a vast array of fundamental metabolic processes.
Zhipeng Zhu, Min Song, Jianxun Ren, Lirong Liang, Guohua Mao, Min Chen   +5 more
doaj   +2 more sources

TREK-1 in central nervous system diseases [PDF]

Chinese Medical Journal
Man Chen, Yile Wang, Zhen Xiong, Yongkang Fang, Zhou Zhu, Ting Gao   +5 more
doaj   +2 more sources

Mitochondrion-based organellar therapies for central nervous system diseases [PDF]

Cell Communication and Signaling
As most traditional drugs used to treat central nervous system (CNS) diseases have a single therapeutic target, many of them cannot treat complex diseases or diseases whose mechanism is unknown and cannot effectively reverse the root changes underlying ...
Mengke Zhao, Jiayi Wang, Shuaiyu Zhu, Meina Wang, Chong Chen, Liang Wang, Jing Liu   +6 more
doaj   +2 more sources

Piezo1: the key regulators in central nervous system diseases [PDF]

Frontiers in Cellular Neuroscience
The occurrence and development of central nervous system (CNS) diseases is a multi-factor and multi-gene pathological process, and their diagnosis and treatment have always posed a serious challenge in the medical field. Therefore, exploring the relevant
Yi Xu, Yuheng Wang, Yanling Yang, Xiaowei Fang, Lidong Wu, Jialing Hu, Jin Li, Shuchong Mei   +7 more
doaj   +2 more sources

Brainstem syndrome at onset is related to an early MS diagnosis in Peru: A national referral center cohort

Heliyon, 2021
Background: MS is unpredictable regarding clinical symptoms; however, certain symptoms represent the preferred localization of white matter lesions such as brainstem, spinal cord; or optic nerve.
César Caparó-Zamalloa, Sheila Castro-Suarez, Jaqueline Cortez-Escalante, Wilfor Aguirre-Quispe, Erik Guevara-Silva, Victor Osorio-Marcatinco, María Meza-Vega   +6 more
doaj   +1 more source